A A
RSS

Research and Markets: Malignant Mesothelioma Therapeutics – Pipeline … – PharmiWeb.com (press release)

Thu, Nov 3, 2011

Alimta News


Research and Markets: Malignant Mesothelioma Therapeutics - Pipeline ...
PharmiWeb.com (press release)
The current malignant mesothelioma therapeutics market is dominated by the chemotherapeutic regimen, Alimta (pemetrexed), which is a folate antimetabolite in combination with cisplatin. The expected launch of NGR-hTNF (combination of a tumour homing ...

and more »

Comments are closed.

«
»
2009 About Alimta Asbestos Attorney Attorneys California Cancer Causes Chemotherapy Deadly Diagnosis Exposure Facts Finding Firm Foundation From Help Information Know Lawsuit Lawsuits Lawyer Lawyers Lung Malignant Mesothelioma Options Overview Patients Pericardial Peritoneal Pleural Research Risk Settlement Simmons Symposium Symptoms Treatment Treatments Types Victims York

Tags

2009 About Alimta Asbestos Attorney Attorneys California Cancer Causes Chemotherapy Deadly Diagnosis Exposure Facts Finding Firm Foundation From Help Information Know Lawsuit Lawsuits Lawyer Lawyers Lung Malignant Mesothelioma Options Overview Patients Pericardial Peritoneal Pleural Research Risk Settlement Simmons Symposium Symptoms Treatment Treatments Types Victims York

Alimta Mesothelioma Pages

Recent Posts

Resources

Latest Videos

Categories

Archives